Correlation Between Erasca and Fate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Erasca and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Fate Therapeutics, you can compare the effects of market volatilities on Erasca and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Fate Therapeutics.

Diversification Opportunities for Erasca and Fate Therapeutics

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Erasca and Fate is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Erasca i.e., Erasca and Fate Therapeutics go up and down completely randomly.

Pair Corralation between Erasca and Fate Therapeutics

Given the investment horizon of 90 days Erasca Inc is expected to generate 0.7 times more return on investment than Fate Therapeutics. However, Erasca Inc is 1.42 times less risky than Fate Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.46 per unit of risk. If you would invest  292.00  in Erasca Inc on September 28, 2024 and sell it today you would lose (30.00) from holding Erasca Inc or give up 10.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Erasca Inc  vs.  Fate Therapeutics

 Performance 
       Timeline  
Erasca Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Erasca is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Erasca and Fate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Erasca and Fate Therapeutics

The main advantage of trading using opposite Erasca and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.
The idea behind Erasca Inc and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments